Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1995-06-07
2000-12-26
Badio, Barbara
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, A61K 3159, C07C40100
Patent
active
061660000
ABSTRACT:
1.alpha.,24(S)-Dihydroxy vitamin D.sub.2 which is useful as an active compound of pharmaceutical compositions for the treatment of disorders of calcium metabolism and for various skin disorders. The invention also includes preparation of synthetic 1.alpha.,24(S)-dihydroxy vitamin D.sub.2 starting from ergosterol which is converted in six steps to 24-hydroxyergosterol. 24-Hydroxyergosterol is irradiated and thermally converted to 24-hydroxy vitamin D.sub.2 which is converted in six steps to 1.alpha.,24(S)-dihydroxy vitamin D.sub.2. The syntheses also produced novel intermediates.
REFERENCES:
patent: 3880894 (1975-04-01), DeLuca et al.
patent: 4022891 (1977-05-01), Takeshita et al.
patent: 4159326 (1979-06-01), Barton et al.
patent: 4195027 (1980-03-01), DeLuca et al.
patent: 4338250 (1982-07-01), DeLuca et al.
patent: 4670190 (1987-06-01), Hesse et al.
patent: 4719205 (1988-01-01), DeLuca et al.
patent: 4866048 (1989-09-01), Calverley et al.
patent: 4960716 (1990-10-01), Harvey et al.
patent: 4973721 (1990-11-01), Ikekawa et al.
patent: 5093519 (1992-03-01), Bouillon et al.
patent: 5098899 (1992-03-01), Gilbert et al.
patent: 5232836 (1993-08-01), Bouillon et al.
patent: 5242824 (1993-09-01), Hellstrom et al.
patent: 5401731 (1995-03-01), Calverley et al.
patent: 5763428 (1998-06-01), Knutson et al.
Shieh et al., "Evaluation of the cytotoxic mechanisms mediated by the broad-spectrum antitumor alkaloid acronycine and selected semisynthetic derivatives". Chem. Biol. Interact. vol. 81, 35-55, 1992.
R. Belsey, H. F. DeLuca and J. T. Potts, Jr., Rapid Communications, pp. 554-557 (1971).
E. G. Bligh and W. J. Dyer, Canadian Journal of Biochemistry and Physiology, vol. 37, pp. 911-917 (1959).
H. F. DeLuca and V. K. Ostrem, Prog. Clin. Biol. Res., vol. 259, pp. 41-55 (1988).
M. F. Holick, A. Kleiner-Bossallier, H. K. Schnoes, P. M. Kasten, I. T. Boyle and H. F. DeLuca, J. Biol. Chem., vol. 248, pp. 6691-6696 (1973).
B. W. Hollis, Clin. Chem., vol. 32, No. 11, pp. 2060-2063 (1986).
R. L. Horst, N. J. Koszewski and T. A. Reinhardt, Biochem., vol. 29, pp. 578-582 (1990).
S. Ishizuka, K. Bannai, T. Naruchi and Y. Hashimoto, Steroids, vol. 37, No. 1, pp. 33-42 (1981).
S. Ishizuka, K. Bannai, T. Naruchi and Y. Hashimoto, Steroids, vol. 39, No. 1, pp. 53-62 (1982).
G. Jones, Clin. Chem., vol. 24, No. 2, pp. 287-298 (1978).
G. Jones, A. Rosenthal, D. Segev, Y. Mazur, F. Frolow, Y. Halfon, D. Rabinovich, and Z. Shakked, Biochemistry, vol. 18, No. 6, pp. 1094-1101 (1979).
G. Jones, H. K. Schnoes, L. Levan and H. F. DeLuca, Archives of Biochemistry and Biophysics, vol. 202, No. 2, pp. 450-457 (1980).
H. E. Paaren, H. F. DeLuca and H. K. Schnoes, J. Org. Chem., vol. 45, pp. 3253-3258 (1980).
J. G. Rheinwald and H. Green, Cell, vol. 6, pp. 331-343 (1975).
H. L. Shieh, J. M. Pezzuto and G. A. Cordell, Chem.-Biol. Interact., vol. 81, pp. 35-55 (1992).
S. Strugnell, M. J. Calverley and G. Jones, Biochemical Pharmacology, vol. 40, pp. 333-341 (1990).
S. Tam, S. Strugnell, R. G. Deeley and G. Jones, Journal of Lipid Research, vol. 29, pp. 1637-1642 (1988).
Calcium Regulation and Bone Metabolism Basic and Clinical Aspects, vol. 9 in R. L. Horst, N. A. Koszewski and T. A. Reinhardt,Quantitation and Biological Evaluation of the C-24 Hydroxylation Pathway of Vitamin D.sub.2, Excerpta Medica, Amsterdam-New York-Oxford, p. 598, 1987.
Analytical Biochemistry, vol. 162, 1987, N. J. Koszewski, T. A. Reinhardt, D. C. Beitz, J. L. Napoli, E. G. Baggiolini, M. R. Uskokovic, and R. L. Horst, "Use of Fourier Transform .sup.1 H NMR in the Identification of Vitamin D.sub.2 Metabolites", pp. 446-452.
Archives of Biochemistry and Biophysics, vol. 270, No. 2, May 1, 1989, G. W. Engstrom and N. J. Koszewski, "Metabolism of Vitamin D.sub.2 in Pig Liver Homogenates: Evidence for a Free Radical Reaction", pp. 432-440.
Biochemistry, vol. 29, No. 4, 1990, G. S. Reddy and K. Tserng, "24,25,28-Trihydroxyvitamin D.sub.2 and 24,25,26-Trihydroxyvitamin D.sub.2 : Novel Metabolites of Vitamin D.sub.2 ", pp. 943-949.
Bishop Charles W.
Jones Glenville
Knutson Joyce C.
Strugnell Stephen
Badio Barbara
Bone Care International, Inc.
LandOfFree
Methods for preparation and use of 1.alpha.,24(S)-Dihydroxy vita does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for preparation and use of 1.alpha.,24(S)-Dihydroxy vita, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for preparation and use of 1.alpha.,24(S)-Dihydroxy vita will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-994988